Literature DB >> 12637698

Secondary prevention of stroke in Italy: a cross-sectional survey in family practice.

Alessandro Filippi1, Angelo Antonio Bignamini, Emiliano Sessa, Fabio Samani, Giampiero Mazzaglia.   

Abstract

BACKGROUND: Hypertension control and antiplatelet or oral anticoagulant drugs are the basis for secondary prevention of cerebrovascular events. Family physicians (FPs) are usually involved in both aspects of prevention, but no research has been carried out in Italy to evaluate the behavior of FPs in this field of prevention.
METHODS: Data concerning 318 Italian FPs and 465,061 patients were extracted from the Health Search Database. Patients with coded diagnoses of stroke and transient ischemic attack (TIA) were selected. Demographic records and information regarding presence of concurrent disease and medical records were also obtained. Logistic regression analyses were carried out to assess whether conditions exist that make appropriate control of blood pressure (BP) and prescription of antiplatelet or anticoagulant drugs more likely.
RESULTS: We selected 2555 patients with diagnosis of stroke and 2755 with TIA. Among all of the subjects, 32.6% had no BP recorded. Among the remaining subjects, 58.7% reported uncontrolled BP. Isolated systolic hypertension has been shown in 68.8% of patients with uncontrolled BP. Antiplatelet and anticoagulant drugs were prescribed in 72% of these cases. Factors that made the prescription significantly more unlikely were diagnosis of TIA (odds ratio [OR], 0.47; 95% confidence interval [CI], 0.41 to 0.54), total invalidity (OR, 0.66; 95% CI 0.56 to 0.78), and time from event of 5 years or more (OR, 0.81; 95% CI, 0.70 to 0.94).
CONCLUSIONS: Italian FPs could improve secondary prevention of cerebrovascular accidents. The primary target of intervention should be the control of systolic BP, and the group of patients with unacceptably high BP should be given priority. All of these patients should have been prescribed antiplatelet drugs or anticoagulant agents, except in cases of extremely short life expectancy or substantial contraindications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12637698     DOI: 10.1161/01.STR.0000062888.90293.AA

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

1.  Recurrent Ischemic Stroke Characteristics and Assessment of Sufficiency of Secondary Stroke Prevention.

Authors:  Gülşen Kocaman; Hümeyra Dürüyen; Abdulkadir Koçer; Talip Asil
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

2.  Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002.

Authors:  Gianluca Trifirò; Edoardo Spina; Ovidio Brignoli; Emiliano Sessa; Achille P Caputi; Giampiero Mazzaglia
Journal:  Eur J Clin Pharmacol       Date:  2005-01-22       Impact factor: 2.953

3.  Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?

Authors:  Lara Monesi; Fausto Avanzini; Simona Barlera; Vittorio Caimi; Davide Lauri; Paolo Longoni; Daria Roccatagliata; Massimo Tombesi; Gianni Tognoni; Maria Carla Roncaglioni
Journal:  Eur J Clin Pharmacol       Date:  2005-07-15       Impact factor: 2.953

4.  Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.

Authors:  Elisabetta Poluzzi; Petar Strahinja; Alberto Vaccheri; Antonio Vargiu; Maria Chiara Silvani; Domenico Motola; Giulio Marchesini; Fabrizio De Ponti; Nicola Montanaro
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

5.  Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people.

Authors:  Ilaria Ardoino; Raffaella Rossio; Donnatella Di Blanca; Alessandro Nobili; Luca Pasina; Pier Mannuccio Mannucci; Flora Peyvandi; Carlotta Franchi
Journal:  Br J Clin Pharmacol       Date:  2017-08-01       Impact factor: 4.335

6.  Stroke due to atrial fibrillation and the attitude to prescribing anticoagulant prevention in Italy. A prospective study of a consecutive stroke population admitted to a comprehensive stroke unit.

Authors:  C Gandolfo; M Balestrino; A Burrone; M Del Sette; C Finocchi
Journal:  J Neurol       Date:  2008-06-20       Impact factor: 4.849

7.  Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.

Authors:  Leonardo Emberti Gialloreti; Monica Merito; Patrizio Pezzotti; Luigi Naldi; Antonio Gatti; Maud Beillat; Laurence Serradell; Rafaelle di Marzo; Antonio Volpi
Journal:  BMC Infect Dis       Date:  2010-08-03       Impact factor: 3.090

8.  Exploring patient- and doctor-related variables associated with antibiotic prescribing for respiratory infections in primary care.

Authors:  Giampiero Mazzaglia; Achille P Caputi; Alessandro Rossi; Germano Bettoncelli; Giovanni Stefanini; Giuseppe Ventriglia; Roberto Nardi; Ovidio Brignoli; Claudio Cricelli
Journal:  Eur J Clin Pharmacol       Date:  2003-09-12       Impact factor: 2.953

9.  Management of patients with suspected angina, but without known myocardial infarction: a cross-sectional survey.

Authors:  Alessandro Filippi; Gianfranco Gensini; Angelo A Bignanimi; Andrea Sabatini; Giampiero Mazzaglia; Claudio Cricelli
Journal:  Br J Gen Pract       Date:  2004-06       Impact factor: 5.386

10.  Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study.

Authors:  Roberto Minutolo; Francesco Lapi; Paolo Chiodini; Monica Simonetti; Elisa Bianchini; Serena Pecchioli; Iacopo Cricelli; Claudio Cricelli; Gaetano Piccinocchi; Giuseppe Conte; Luca De Nicola
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-29       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.